Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Santander
Clinical trial register · Spain

Clinical Trials in Santander, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 188 Madrid 183 Seville 71 Málaga 66 Valencia 60
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca40 Janssen Research & Development, LLC24 Bristol-Myers Squibb16 AbbVie16 Merck Sharp & Dohme LLC15 Clear sponsor filter
Site location
Barcelona188 Madrid183 Seville71 Málaga66 Valencia60
All 103 locations
Target enrolment
to

Trials with a site in Santander

40 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
AstraZeneca
Phase 3
750
Badalona, Barcelona, El Palmar, Madrid, Salamanca, Santander, Seville
2026-08-25
Recruiting
AstraZeneca
Phase 3
915
L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Santander, Seville
2026-07-16
Recruiting
AstraZeneca
Phase 3
900
Barcelona, Ferrol, Lleida, Madrid, Majadahonda, Málaga, Santander, Seville
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
A Coruña, Almería, Badalona, Barcelona, León, Madrid, Santander, Santiago de Compostela
2026-06-29
Recruiting
AstraZeneca
Phase 3
245
Barcelona, Córdoba, Galdakao, Madrid, Sabadell, Santander, Seville, Valencia
2026-04-13
Recruiting
AstraZeneca
Phase 3
508
Barcelona, Madrid, Pamplona, Salamanca, Santander, Valencia
2026-02-23
Recruiting
AstraZeneca
Phase 3
2,130
Barcelona, Madrid, Pamplona, Santander, Santiago de Compostela, Valencia
2026-02-03
Recruiting
AstraZeneca
Phase 3
1,100
Barcelona, L'Hospitalet de Llobregat, Madrid, Santander
2025-12-04
Recruiting
AstraZeneca
Phase 1/2
83
Badalona(Barcelona), Barcelona, Salamanca, Santander, Valencia
2025-11-12
Recruiting
AstraZeneca
Phase 1/2
283
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Santander, Valencia
2025-10-01
Active, closed
AstraZeneca
Phase 3
68
A Coruña, Badajoz, Barakaldo, Barcelona, Madrid, Málaga, Oviedo, Santander
2025-09-15
Recruiting
AstraZeneca
Phase 2
278
A Coruña, Madrid, Manresa, Málaga, Santander, Valencia
2025-08-07
Recruiting
AstraZeneca
Phase 3
700
Barcelona, Girona, Madrid, Majadahonda, Málaga, Oviedo, Sabadell, Santander
2025-08-06
Recruiting
AstraZeneca
Phase 2
100
Barcelona, Elche, Madrid, Málaga, Ourense, Oviedo, Santander, Valencia
2025-07-17
Recruiting
AstraZeneca
Phase 2
987
Benalmádena, Granollers, Madrid, Málaga, Mérida, Pozuelo de Alarcón, Santander
2025-06-27
Recruiting
AstraZeneca
Phase 3
1,220
Barcelona, Madrid, Santander
2025-05-06
Recruiting
AstraZeneca
Phase 2
540
Barcelona, Madrid, Málaga, Mérida, Patraix, Santander
2025-03-26
Recruiting
AstraZeneca
Phase 2
80
Barcelona, Madrid, Málaga, Pamplona, Santander, Valencia
2025-03-12
Recruiting
AstraZeneca
Phase 3
840
Badalona, Barcelona, Madrid, Ourense, Santander, Seville, Valencia
2025-03-01
Active, closed
AstraZeneca
Phase 2
194
A Coruña, Alcorcón, Barcelona, Madrid, Málaga, Pamplona, Santander, Santiago de Compostela
2024-08-27
Recruiting
AstraZeneca
Phase 3
620
Barcelona, Madrid, Málaga, Santander
2024-08-12
Recruiting
AstraZeneca
Phase 3
1,018
Barcelona, El Palmar, Girona, Las Palmas de Gran Canaria, Madrid, Oviedo, Pamplona, Santander
2024-08-07
Active, closed
AstraZeneca
Phase 3
594
Barcelona, Madrid, Ourense, Santander, Seville
2024-03-04
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Santiago de Compostela, Zaragoza, Poniente Sur, Santander, Burgos, Ourense, Majadahonda, El Palmar
2023-12-20
Active, closed
AstraZeneca
Phase 3
760
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona, Santander
2023-12-04
Recruiting
AstraZeneca
Phase 3
625
Barcelona, Granada, Hospitalet deLlobregat, Madrid, Pamplona, Santander
2023-11-23
Recruiting
AstraZeneca
Phase 2
163
Barcelona, Elche(Alicante), L'Hospitalet de Llobregat, Madrid, Santander
2023-01-16
Active, closed
AstraZeneca
Phase 3
1,350
Las Palmas de Gran Canaria, Lugo, Madrid, Santander, Seville, Valencia, Zaragoza
2022-12-29
Recruiting
AstraZeneca
Phase 3
3,527
Barcelona, Madrid, Majadahonda, Málaga, Ourense, Palma de Mallorca, Pamplona, Santander
2022-12-13
Active, closed
AstraZeneca
Phase 3
506
Barcelona, Bilbao (Vizcaya), Granada, Madrid, Salamanca, Santander, Santiago de Compostela-Coruña, Seville
2021-06-22
Active, closed
AstraZeneca
Phase 3
1,371
Barcelona, Jaén, Lleida, Madrid, Málaga, Pamplona, Santander, Seville
2021-01-28
Active, closed
AstraZeneca
Phase 3
957
Barcelona, Madrid, Málaga, Ourense, Santander, Seville, Valencia
2020-11-17
Active, closed
AstraZeneca
Phase 3
640
Barcelona, Córdoba, Madrid, Pamplona, Santander, Zaragoza
2020-10-19
Active, closed
AstraZeneca
Phase 3
134
Santander
2020-07-20
Active, closed
AstraZeneca
Phase 3
1,012
Badalona (Barcelona), Barcelona, Las Palmas de Gran Canaria, Madrid, Oviedo, Santander, Seville
2020-07-13
Active, closed
AstraZeneca
Phase 2
452
Barcelona, Madrid, Santander, Seville
2020-06-03
Active, closed
AstraZeneca
Phase 3
1,063
Badalona, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Santander, Seville
2018-11-16
Active, closed
AstraZeneca
Phase 3
1,246
Barcelona, Lugo, Madrid, Málaga, Santander, Seville
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,324
Barcelona, Madrid, Oviedo, Pamplona Madrid, Santander
2017-10-11
Active, closed
AstraZeneca
Phase 3
987
A Coruña, Badajoz, Badalona, Barcelona, Madrid, Santander, Valencia, Zaragoza
2017-03-27
Rows per page Showing 1–40 of 40
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/santander

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 40 of those studies with a site in Santander that also match the filters currently applied.

How many clinical trials are recruiting in Santander?

23 of the 40 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Santander), 40 studies
PhaseStudiesRecruitingShare
Phase 3291472.5%
Phase 28620%
Phase 1/2225%
Observational112.5%

Most active sponsors

Lead sponsors with the most studies (Santander)
Lead sponsorStudiesRecruiting
AstraZeneca4023
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.